Newamsterdam Pharma Stock Price History
NAMSW Stock | 9.06 0.63 6.50% |
If you're considering investing in NewAmsterdam Stock, it is important to understand the factors that can impact its price. As of today, the current price of NewAmsterdam Pharma stands at 9.06, as last reported on the 1st of December, with the highest price reaching 9.06 and the lowest price hitting 8.62 during the day. NewAmsterdam Pharma appears to be relatively risky, given 3 months investment horizon. NewAmsterdam Pharma has Sharpe Ratio of 0.0945, which conveys that the firm had a 0.0945% return per unit of risk over the last 3 months. By analyzing NewAmsterdam Pharma's technical indicators, you can evaluate if the expected return of 0.62% is justified by implied risk. Please exercise NewAmsterdam Pharma's Downside Deviation of 8.44, mean deviation of 3.86, and Risk Adjusted Performance of 0.052 to check out if our risk estimates are consistent with your expectations.
At this time, NewAmsterdam Pharma's Common Stock Shares Outstanding is fairly stable compared to the past year. Stock Based Compensation is likely to climb to about 23.4 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 225.3 M in 2024. . At this time, NewAmsterdam Pharma's Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to climb to 3.02 in 2024, despite the fact that Price Earnings To Growth Ratio is likely to grow to (0.05). NewAmsterdam Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
NewAmsterdam |
Sharpe Ratio = 0.0945
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | NAMSW | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
6.56 actual daily | 58 58% of assets are less volatile |
Expected Return
0.62 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average NewAmsterdam Pharma is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NewAmsterdam Pharma by adding it to a well-diversified portfolio.
Book Value 4.111 | Shares Float 36.3 M | Shares Short Prior Month 5 K | Shares Short 3.5 K | Revenue Per Share 0.373 |
NewAmsterdam Pharma Stock Price History Chart
There are several ways to analyze NewAmsterdam Stock price data. The simplest method is using a basic NewAmsterdam candlestick price chart, which shows NewAmsterdam Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 12, 2024 | 13.85 |
Lowest Price | September 25, 2024 | 6.42 |
NewAmsterdam Pharma December 1, 2024 Stock Price Synopsis
Various analyses of NewAmsterdam Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell NewAmsterdam Stock. It can be used to describe the percentage change in the price of NewAmsterdam Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of NewAmsterdam Stock.NewAmsterdam Pharma Price Daily Balance Of Power | (1.43) | |
NewAmsterdam Pharma Price Action Indicator | (0.09) | |
NewAmsterdam Pharma Price Rate Of Daily Change | 0.93 |
NewAmsterdam Pharma December 1, 2024 Stock Price Analysis
NewAmsterdam Stock Price History Data
The price series of NewAmsterdam Pharma for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 7.43 with a coefficient of variation of 24.02. The daily prices for the period are spread out with arithmetic mean of 8.78. The median price for the last 90 days is 8.45. The company underwent 1:1 stock split on 23rd of November 2022.Open | High | Low | Close | Volume | ||
12/01/2024 | 8.62 | 9.06 | 8.62 | 9.06 | ||
11/29/2024 | 8.62 | 9.06 | 8.62 | 9.06 | 1,116 | |
11/27/2024 | 10.03 | 10.03 | 9.50 | 9.69 | 10,020 | |
11/26/2024 | 10.15 | 10.15 | 9.20 | 9.53 | 6,263 | |
11/25/2024 | 9.37 | 10.56 | 9.37 | 10.15 | 16,616 | |
11/22/2024 | 9.20 | 9.30 | 8.87 | 8.90 | 6,655 | |
11/21/2024 | 9.97 | 9.97 | 9.02 | 9.02 | 9,692 | |
11/20/2024 | 11.10 | 11.10 | 9.23 | 9.45 | 31,699 | |
11/19/2024 | 12.60 | 14.14 | 12.29 | 13.11 | 25,521 | |
11/18/2024 | 13.30 | 13.60 | 13.23 | 13.23 | 6,578 | |
11/15/2024 | 13.50 | 13.50 | 13.02 | 13.30 | 13,400 | |
11/14/2024 | 13.65 | 13.66 | 13.45 | 13.59 | 5,030 | |
11/13/2024 | 13.85 | 16.00 | 12.95 | 13.37 | 29,645 | |
11/12/2024 | 12.81 | 14.25 | 12.81 | 13.85 | 8,276 | |
11/11/2024 | 12.87 | 12.87 | 12.81 | 12.81 | 406.00 | |
11/08/2024 | 13.23 | 13.28 | 12.33 | 12.91 | 18,075 | |
11/07/2024 | 13.32 | 14.40 | 12.30 | 12.46 | 23,909 | |
11/06/2024 | 10.30 | 12.80 | 10.30 | 12.50 | 26,092 | |
11/05/2024 | 10.00 | 10.47 | 9.71 | 10.20 | 19,136 | |
11/04/2024 | 8.40 | 10.00 | 8.40 | 9.80 | 7,929 | |
11/01/2024 | 8.02 | 8.20 | 8.00 | 8.00 | 2,238 | |
10/31/2024 | 8.00 | 9.39 | 7.81 | 8.70 | 13,742 | |
10/30/2024 | 8.90 | 8.90 | 8.90 | 8.90 | 1.00 | |
10/29/2024 | 8.90 | 8.90 | 8.90 | 8.90 | 1.00 | |
10/28/2024 | 8.90 | 8.90 | 8.90 | 8.90 | 1.00 | |
10/25/2024 | 8.90 | 8.90 | 8.90 | 8.90 | 1.00 | |
10/24/2024 | 8.90 | 8.90 | 8.90 | 8.90 | 94.00 | |
10/23/2024 | 8.32 | 8.90 | 8.32 | 8.90 | 320.00 | |
10/22/2024 | 9.00 | 9.10 | 8.64 | 8.64 | 743.00 | |
10/21/2024 | 9.27 | 9.27 | 9.27 | 9.27 | 152.00 | |
10/18/2024 | 9.08 | 9.27 | 9.08 | 9.27 | 620.00 | |
10/17/2024 | 9.00 | 9.00 | 9.00 | 9.00 | 246.00 | |
10/16/2024 | 8.56 | 8.56 | 8.56 | 8.56 | 101.00 | |
10/15/2024 | 8.55 | 8.55 | 8.50 | 8.50 | 699.00 | |
10/14/2024 | 8.65 | 8.66 | 8.45 | 8.45 | 788.00 | |
10/11/2024 | 8.04 | 8.25 | 8.04 | 8.25 | 581.00 | |
10/10/2024 | 8.00 | 8.25 | 8.00 | 8.25 | 1,322 | |
10/09/2024 | 8.00 | 8.00 | 7.70 | 7.98 | 1,840 | |
10/08/2024 | 7.99 | 8.00 | 7.99 | 8.00 | 500.00 | |
10/07/2024 | 8.00 | 8.00 | 7.95 | 8.00 | 20,762 | |
10/04/2024 | 8.00 | 8.20 | 7.77 | 8.20 | 7,758 | |
10/03/2024 | 7.87 | 9.20 | 7.87 | 8.00 | 6,222 | |
10/02/2024 | 7.28 | 7.55 | 7.28 | 7.55 | 3,225 | |
10/01/2024 | 7.00 | 7.25 | 7.00 | 7.25 | 1,307 | |
09/30/2024 | 7.23 | 7.23 | 7.00 | 7.00 | 2,000 | |
09/27/2024 | 6.43 | 6.45 | 6.43 | 6.45 | 418.00 | |
09/26/2024 | 6.42 | 6.42 | 6.42 | 6.42 | 5.00 | |
09/25/2024 | 6.35 | 6.42 | 6.35 | 6.42 | 201.00 | |
09/24/2024 | 6.25 | 6.92 | 6.24 | 6.92 | 761.00 | |
09/23/2024 | 6.95 | 6.95 | 6.43 | 6.80 | 1,582 | |
09/20/2024 | 6.97 | 6.97 | 6.97 | 6.97 | 1.00 | |
09/19/2024 | 6.76 | 6.97 | 6.76 | 6.97 | 8,202 | |
09/18/2024 | 6.89 | 6.95 | 6.89 | 6.95 | 1,972 | |
09/17/2024 | 6.71 | 6.71 | 6.71 | 6.71 | 1.00 | |
09/16/2024 | 6.71 | 6.71 | 6.71 | 6.71 | 1.00 | |
09/13/2024 | 6.71 | 6.71 | 6.71 | 6.71 | 1.00 | |
09/12/2024 | 6.71 | 6.71 | 6.71 | 6.71 | 203.00 | |
09/11/2024 | 7.07 | 7.10 | 6.49 | 6.74 | 3,250 | |
09/10/2024 | 7.99 | 8.30 | 7.31 | 7.40 | 7,100 | |
09/09/2024 | 6.20 | 8.59 | 6.20 | 7.40 | 1,600 | |
09/06/2024 | 6.97 | 6.97 | 6.97 | 6.97 | 1.00 |
About NewAmsterdam Pharma Stock history
NewAmsterdam Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NewAmsterdam is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NewAmsterdam Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NewAmsterdam Pharma stock prices may prove useful in developing a viable investing in NewAmsterdam Pharma
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 82.2 M | 86.3 M |
NewAmsterdam Pharma Quarterly Net Working Capital |
|
NewAmsterdam Pharma Stock Technical Analysis
NewAmsterdam Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
All Next | Launch Module |
NewAmsterdam Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NewAmsterdam Pharma's price direction in advance. Along with the technical and fundamental analysis of NewAmsterdam Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NewAmsterdam to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.052 | |||
Jensen Alpha | 0.211 | |||
Total Risk Alpha | (0.77) | |||
Sortino Ratio | 0.0296 | |||
Treynor Ratio | 0.2891 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for NewAmsterdam Stock Analysis
When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.